Results 141 to 150 of about 401,116 (169)

Intraventricular Cerliponase Alfa Treatment in a Patient with Advanced Neuronal Ceroid Lipofuscinosis Type 2. [PDF]

open access: yesIntern Med
Nakashima S   +9 more
europepmc   +1 more source

Akap5 links synaptic dysfunction to neuroinflammatory signaling in a mouse model of infantile neuronal ceroid lipofuscinosis. [PDF]

open access: yesFront Synaptic Neurosci
Koster KP   +8 more
europepmc   +1 more source

The neuronal ceroid lipofuscinosis type 2 - associated variants: An analysis of alterations in the <i>TPP1</i> gene and genotype-phenotype correlation in Ukraine. [PDF]

open access: yesJIMD Rep
Olkhovych N   +11 more
europepmc   +1 more source

TPP1 Variants in Iranian patients: A Novel Pathogenic Homozygous Variant Causing Neuronal Ceroid Lipofuscinosis 2. [PDF]

open access: yesMol Syndromol
Vafaei N   +10 more
europepmc   +1 more source

Classic and Atypical Late Infantile Neuronal Ceroid Lipofuscinosis in Latin America: Clinical and Genetic Aspects, and Treatment Outcome with Cerliponase Alfa. [PDF]

open access: yesMol Genet Metab Rep
Guelbert N   +34 more
europepmc   +1 more source

Neuronal Ceroid Lipofuscinosis in Qatar: Report of a Novel Mutation in Ceroid-Lipofuscinosis, Neuronal 5 in the Arab Population

open access: yesJournal of Child Neurology, 2011
This study sought to genetically define the first family diagnosed with neuronal ceroid lipofuscinosis from Qatar. Onset was in late infancy (3 years), and sequencing in the affected children revealed a novel homozygous c.613C>T change in exon 3 of ...
Tawfeg Ben-Omran   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy